OSR Holdings Inc

NASDAQ:OSRH USA Biotechnology
Market Cap
$11.55 Million
Market Cap Rank
#32497 Global
#10668 in USA
Share Price
$0.45
Change (1 day)
-4.26%
52-Week Range
$0.40 - $3.79
All Time High
$5.46
About

OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatme… Read more

OSR Holdings Inc (OSRH) - Total Liabilities

Latest total liabilities as of September 2025: $43.13 Million USD

Based on the latest financial reports, OSR Holdings Inc (OSRH) has total liabilities worth $43.13 Million USD as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

OSR Holdings Inc - Total Liabilities Trend (2020–2024)

This chart illustrates how OSR Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

OSR Holdings Inc Competitors by Total Liabilities

The table below lists competitors of OSR Holdings Inc ranked by their total liabilities.

Liability Composition Analysis (2020–2024)

This chart breaks down OSR Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.21 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.32 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.24 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how OSR Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for OSR Holdings Inc (2020–2024)

The table below shows the annual total liabilities of OSR Holdings Inc from 2020 to 2024.

Year Total Liabilities Change
2024-12-31 $8.79 Million +113.93%
2023-12-31 $4.11 Million +225.19%
2022-12-31 $1.26 Million +78.64%
2021-12-31 $707.21K +119.93%
2020-12-31 $321.56K --